“…Consequently, COVID-19-induced morbidity and mortality risk are directly proportional to age ( Grasselli et al, 2020 ; Team, 2020 ; Zheng et al, 2020 ), and male sex is also a significant risk factor for COVID-19-induced morbidity and mortality ( Grasselli et al, 2020 ). Individuals with metabolic syndrome (obesity ( Kim et al, 2015 ; Lecube et al, 2008 ; Moreno-Navarrete et al, 2017 ), diabetes ( Batchuluun et al, 2014 ; Simcox and McClain, 2013 ; Ma et al, 2018 ), and cardiovascular disease ( Milman and Kirchhoff, 1999 ; Cheng et al, 1999 ; Lee et al, 2018 )) have higher COVID-19-induced morbidity and mortality due to abnormally high iron stores compared to matched-healthy individuals. Several studies have demonstrated that COVID-19 patients exhibit abnormally high iron stores (using serum ferritin levels ( Gordeuk et al, 2008 ; Camaschella and Poggiali, 2009 ) as a surrogate marker) ( Chen et al, 2020 ; Gomez-Pastora et al, 2020 ), and a retrospective, multicenter cohort study of hospitalized COVID-19 patients confirmed that abnormally high iron stores constitute a significant determinant of COVID-19-induced mortality ( Gomez-Pastora et al, 2020 ; Zhou et al, 2020 ; Ruscitti et al, 2020 ; Edeas et al, 2020 ).…”